Abstract
Natural tetrapeptide Goralatide (AcSDKP) is a selective inhibitor of primitive haematopoietic cell proliferation. It is not stable in vivo and decomposes within 4.5 min when applied to live cells. In this work we developed an analog of Goralatide that exhibits cytotoxicity towards human myeloid HL-60, HEL, Nalm-6 leukemia cells, endothelial HUVEC, glioblastoma U251 and transformed kidney 293T cells. The Goralatide analog showed significant stability in organic solution with no tendency to degrade oxidatively.
Original language | English (US) |
---|---|
Pages (from-to) | 5056-5060 |
Number of pages | 5 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 23 |
Issue number | 15 |
DOIs | |
State | Published - Jul 23 2015 |
Keywords
- Anticancer
- Antileukemic
- Goralatide
- Peptide
- Peptidomimetic
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry